Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Experimental Hematology & Oncology|January 8, 2024
Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNAClémence Astier, Carine Ngo, Léo Colmet-Daage, et al.
Cancer|June 14, 2017
Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissuesRobbie G Majzner, Jason S Simon, Joseph F Grosso, et al.
JCI Insight|May 5, 2022
Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explantsTala Tayoun, Vincent Faugeroux, Marianne Oulhen, et al.
Cancers|September 9, 2020
DNA FISH Diagnostic Assay on Cytological Samples of Thyroid Follicular NeoplasmsPhilippe Vielh, Zsofia Balogh, Voichita Suciu, et al.
Oncotarget|January 10, 2018
Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3Stéphanie Buart, Stéphane Terry, Muhammad Z Noman, et al.
Nature Communications|April 22, 2020
Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant modelVincent Faugeroux, Emma Pailler, Marianne Oulhen, et al.
Cell Reports. Medicine|May 23, 2024
Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTsClémence Henon, Julien Vibert, Thomas Eychenne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2024
Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant ChemotherapyElisa Yaniz-Galende, Qinghe Zeng, Juan F Bejar-Grau, et al.
Nature Medicine|July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Elise Deluche, Amelie Lusque, et al.
Cancer Discovery|August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder CancerAnne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
Pageof 3